THRD
Third Harmonic Bio Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$242.79M
P/E Ratio
—
EPS
$-1.24
Beta
2.13
52W High
$5.53
52W Low
$5.17
50-Day MA
$5.40
200-Day MA
$6.51
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Third Harmonic Bio Inc.
Third Harmonic Bio Inc. is an innovative biotechnology company dedicated to developing advanced therapies for severe immunological and inflammatory disorders. Utilizing its proprietary genetic engineering platform, the company is building a robust pipeline of drug candidates aimed at addressing significant unmet medical needs within the biopharmaceutical sector. Committed to scientific excellence and enhancing patient outcomes, Third Harmonic Bio is strategically positioned to reshape the treatment paradigm for patients facing serious health challenges, potentially delivering transformative solutions to the medical community.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-64.25M |
| Operating Margin | 0.00% |
| Return on Equity | -19.90% |
| Return on Assets | -14.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.06 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $45.13M |
| Float | $15.60M |
| % Insiders | 9.11% |
| % Institutions | 80.12% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
64.3%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026